First Bank & Trust Meridian Bioscience Inc Transaction History

First Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$23.75 - $31.69 $45,410 - $60,591	1,912 Added 57.61%	5,231 $159,000
Q1 2022 Apr 29, 2022	SELL	$19.97 - $26.94 $28,696 - $38,712	-1,437 Reduced 30.21%	3,319 $86,000
Q4 2021 Feb 01, 2022	BUY	$17.46 - $21.61 $5,866 - $7,260	336 Added 7.6%	4,756 $97,000
Q2 2021 Aug 10, 2021	BUY	$18.01 - $28.32 $53,669 - $84,393	2,980 Added 206.94%	4,420 $98,000
Q1 2021 Apr 14, 2021	BUY	$19.76 - $29.89 $28,454 - $43,041	1,440 New	1,440 $38,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on First Bank & Trust with notifications on news.